India's Serum Institute starts manufacturing Codagenix's potential Covid-19 vaccine

Codagenix Inc said on Tuesday Serum Institute of India has started manufacturing the US biotech firm's potential Covid-19 vaccine and it expects to begin early-stage human trial by the end of 2020 in the UK. ​Serum Institute, the world's largest vaccine maker by number of doses produced, will develop Codagenix's CDX-005, which is delivered intranasally.

Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.